Last reviewed · How we verify

NCT05996692

Evaluation of Adherence of Women With Fibromyalgia to Walking Prescriptions

Completed Last updated 18 August 2023
What this trial tests

trial testing Evaluation of adherence to walking prescriptions in Fibromyalgia in 100 participants. Completed in 1 June 2023.

Timeline
1 March 2022
Primary endpoint
1 June 2023
1 June 2023

Quick facts

Lead sponsorGaziler Physical Medicine and Rehabilitation Education and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date1 March 2022
Primary completion1 June 2023
Estimated completion1 June 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Who can join

Adults 18 to 70, female only, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although there are many studies evaluating adherence to supervised walking programs in patients with fibromyalgia (FM), there are limited studies evaluating adherence to unsupervised walking programs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Gaziler Physical Medicine and Rehabilitation Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05996692.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing